The FDA has approved Semaglutide GLP-1 injections for long-term use for weight loss
AWARD-6 is a randomized, open, parallel-grouped, multicenter, phase 3, non-inferiority study comparing the safety and efficacy of weekly DUL and daily LIR in patients with uncontrolled T2DM treated with metformin
The study utilized a single-blind, randomized, placebo-controlled, crossover design, combined with functional magnetic resonance imaging (fMRI), to analyze the performance of 54 participants (30 with normal insulin sensitivity and 24 with impaired insulin sensitivity) on sensory associative learning tasks while receiving liraglutide and placebo treatments
The main pathological features of AD include the deposition of insoluble A that forms senile plaques, neurofibrillary tangles, and neuronal apoptosis (40)
Consider whether you're meeting physical activity recommendations (at least 150 minutes of moderate-intensity activity weekly)